Showing 1311-1320 of 8824 results for "".
Cellfina Cleared, Finacea Foam Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-cellfina-cleared-finacea-foam-approved/18866/The FDA has cleared Cellfina (Ulthera Inc./Merz Aesthetics, Inc.) to treat cellulite, with results lasting for up to 2 years. Finacea Foam (azelaic acid, Bayer Dermatology) is approved for Rosacea, and Almirall invests in Suneva Medical, maker of Bellafill. Also in this edition, a look at the data oSocial Media: Top Platforms for Your Practice
https://practicaldermatology.com/topics/practice-management/social-media--avereeno/18998/An Ekwa Educational Video (Ekwa.com). What platforms are best for your practice's social media goals? Learn about the options and how to best use them to engage with patients.SINON by Quantel Derma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/sinon-by-quantel-derma/19387/The ruby laser system with active Q-switch against natural pigmentations and tattoos. The Q-switched ruby laser system SINON has a wavelength of 694 nm. It applies ultra short pulses of only 20 ns for effective treatments even with low fluency. Thus, SINON is fast, reliable and gentle and able to rJune Issue: Melanoma Updates - Epidemiology, Diagnostics, and Treatment
https://practicaldermatology.com/issues/may-june-2025/melanoma-updates-epidemiology-diagnostics-and-treatment/35917/In this article, we review the latest changes in melanoma incidence and mortality, highlight key disparities among minority populations, and summarize emerging trends in technology and treatment that are reshaping the future of melanoma care.FDA Approval for Delgocitinib
https://practicaldermatology.com/series/c-suite-chats/fda-approval-for-delgocitinib/36650/Robert Spurr, EVP, North America for LEO Pharma, discusses the importance of an FDA-approved option for treating moderate-to-severe chronic hand eczema in adults.New Treatment Option for Androgenetic Alopecia
https://practicaldermatology.com/series/c-suite-chats/new-treatment-option-for-androgenetic-alopecia/32969/Reid Waldman, MD, Co-Founder and CEO of Veradermics, discusses the prevalence of androgenetic alopecia-pattern hair loss and the company's investigational treatment candidate.Noah Worcester 2024: Dr. Bettencourt on Beach Vacations
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-bettencourt-beach-vacations/24591/Miriam Bettencourt, MD, summarizes her lecture about problems that can be encountered during beach vacations at the 2024 Noah Worcester Dermatological Society meeting.Advocating for Dermatology: The Benefits of Being Involved
https://practicaldermatology.com/topics/practice-management/advocating-for-dermatology-the-benefits-of-being-involved/20087/Neal Bhatia, MD shares his appreciation for being able to have served as the American Academy of Dermatology’s Vice President for the last year. He shares his thoughts on the importance of getting involved and advocating for the specialty.Case Reports: Aesthetic Dermatology Successes
https://practicaldermatology.com/conferences/maui-derm-2022/case-reports-aesthetic-dermatology-successes/20050/Ava Shamban, MD highlights three cases she presented to show why she uses a carboxy lift mask to promote healing and improve side effects from laser procedures; the benefits of the Revance RHA Collection of Fillers to treat dynamic lines and wrinkles; and the effectiveness of hyperdilute Radiesse toFive ways to market for the “next normal”
https://practicaldermatology.com/topics/practice-management/five-ways-to-market-for-the-next-normal/20015/You’ve heard it time and time again. The “new normal.” We have been living and working within this new environment for almost two years. In this Ekwa Marketing video, we ask, “What is the next normal?” We isolate five ways to market for tomorrow’s increasingly digitally savvy, curious, socially awar